Dr. Issame Outaleb

AI Expert, Serial entrepreneur, CEO of PharmaTrace - Senior Pharma Management Consultant- Blockchain NFT and Web3 Expert- Angel Investor

Greater Munich Metropolitan Area

About

Specialities in Pharma & Healthcare: AI Agentics and digital tools Medical affairs Change Management Commercial excellence Digital transformation Market access and innovation - Healthcare Landscape Assessment in EU5 and USA Experience: - Medical strategy and affairs - Brand and Portfolio Strategy - Market Access and Pricing - Key Account Planning - Project Management - Market Assessment - Market Launch Audit and Planning - Business Development - Market Access and Pricing - Reimbursement Scenarios - Launch Strategies - Biosimilars Lansdscaping - Forecasting and modeling Life Science - Immunobiology expertise through PhD thesis - Therapeutic areas including Infection Diseases, Pulmonary, Oncology, Cardiology and Orphan/ Rare Diseases, Alzheimer, Asthma, Digestive Health Med Devices

Experience

  • Rare Diseases Neuro- AI in Medical and Vommercial launch excellence DACH at ITF Pharma GmbH
    Jul 2023 - Present · 3 yrs 1 mo

    Developing AI Tools for Medical and Comercial processes Medical planing Commercial Excellence COO budgeting and Organisation Pricing market access plan Launch readiness activities Forecasting - Business and Patients GM activities support

  • Founder and CEO at PharmaTrace
    Jun 2017 - Present · 9 yrs 2 mos

    Blockchain and AI based startup focusing on Healthcare and Phama Suppply Chain, Track and Trace, Recalls, Serialization, B2B connections data security, Smart Contracts, Complexe Processing, and Cost savings within Healthcare Ecosystem

  • Managing Partner at Kuiper Partners Management Consulting
    Jan 2022 - Present · 4 yrs 7 mos

    www.kuiperpartners.com

  • Freelancer - Pharma Management Senior Consultant at -
    Nov 2016 - Present · 9 yrs 9 mos

    Change Management Strategic Operations- (Nov 2019-Ongoing) Frankfurt - Ophthalmology (PE) FASENRA Launch planning & SFE & Blockchain deployment case studies -- AstraZeneca (Nov2018- July 2019) Growth Strategies lead – Korian Group EU leader in Care sector *Align on core messaging across centers *Cross-functional workshop series *Enhance multichannel communications and Ads *Customer segmentation and needs GlobL pricing market access strategist - Shire Zurich * Pricing scenarios - Hematology * Strategic brand planning - Hematology Business and Market intelligence Lead - Teva Paris * Operations and Business Plan * Market insights * Process and Sales Optimization PMO Lead Oncology – Top 3 Onco Player Berlin * Support growth opportunities within Region (EU) * Medical Strategic Planning and MSL Excellence * Sales Training App development and integration * KAP and Engagement and Segmentation PM Support- Biosimilars Oncology and RA – Sandoz Munich * Biosimilar market launch strategy and planning * Pricing strategies * Market access, Competitive Intel * Go to Market Strategy * Key account planning and segmentation * Project management * Top management presentation

  • Biosimilars Interim Senior Director at STADA Group
    Mar 2023 - Jan 2026 · 2 yrs 11 mos

    Biosimilars and specialty care - CI and GTM R&D road map Competitive intelligence Digital business solutions Business intelligence Artificial intelligence platform